Several studies have shown that CUL1 is upregulated in many cancers and is associated with poor patient prognosis in various cancers, including gastric, breast, renal cell carcinoma, colorectal, and hepatocellular carcinoma (54, –, 58). Here, CUL1 is linked to cancer.